CytRx ROA 2006-2020 | CYTR

Current and historical return on assets (ROA) values for CytRx (CYTR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
CytRx ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $-0.01B $0.02B -49.23%
2020-06-30 $-0.01B $0.02B -34.29%
2020-03-31 $-0.01B $0.02B -32.43%
2019-12-31 $-0.01B $0.02B -30.38%
2019-09-30 $-0.01B $0.02B -23.53%
2019-06-30 $-0.01B $0.02B -28.57%
2019-03-31 $-0.01B $0.02B -29.51%
2018-12-31 $-0.01B $0.02B -33.57%
2018-09-30 $-0.01B $0.03B -33.33%
2018-06-30 $-0.02B $0.04B -34.59%
2018-03-31 $-0.03B $0.04B -54.27%
2017-12-31 $-0.03B $0.05B -65.07%
2017-09-30 $-0.04B $0.05B -67.86%
2017-06-30 $-0.05B $0.06B -75.63%
2017-03-31 $-0.05B $0.05B -81.67%
2016-12-31 $-0.05B $0.06B -77.86%
2016-09-30 $-0.07B $0.06B -97.74%
2016-06-30 $-0.06B $0.06B -86.02%
2016-03-31 $-0.05B $0.08B -76.60%
2015-12-31 $-0.06B $0.07B -83.99%
2015-09-30 $-0.05B $0.08B -66.67%
2015-06-30 $-0.05B $0.06B -61.25%
2015-03-31 $-0.05B $0.07B -58.40%
2014-12-31 $-0.03B $0.09B -29.70%
2014-09-30 $-0.04B $0.10B -48.89%
2014-06-30 $-0.05B $0.11B -66.90%
2014-03-31 $-0.04B $0.12B -66.67%
2013-12-31 $-0.05B $0.04B -144.62%
2013-09-30 $-0.02B $0.02B -50.00%
2013-06-30 $-0.00B $0.03B -12.50%
2013-03-31 $-0.01B $0.04B -43.75%
2012-12-31 $-0.02B $0.04B -53.97%
2012-09-30 $-0.03B $0.02B -80.65%
2012-06-30 $-0.03B $0.03B -77.24%
2012-03-31 $-0.02B $0.03B -49.66%
2011-12-31 $-0.01B $0.04B -38.62%
2011-09-30 $-0.01B $0.05B -16.67%
2011-06-30 $-0.01B $0.03B -25.53%
2011-03-31 $-0.01B $0.03B -12.82%
2010-12-31 $0.00B $0.04B 0.00%
2010-09-30 $-0.01B $0.04B -15.29%
2010-06-30 $0.00B $0.04B 5.26%
2010-03-31 $-0.00B $0.04B -3.10%
2009-12-31 $-0.00B $0.04B -13.56%
2009-09-30 $-0.01B $0.04B -21.62%
2009-06-30 $-0.02B $0.02B -80.00%
2009-03-31 $-0.03B $0.03B -78.79%
2008-12-31 $-0.03B $0.03B -70.89%
2008-09-30 $-0.03B $0.04B -61.86%
2008-06-30 $-0.02B $0.04B -40.71%
2008-03-31 $-0.02B $0.05B -35.94%
2007-12-31 $-0.02B $0.06B -36.21%
2007-09-30 $-0.02B $0.07B -37.91%
2007-06-30 $-0.02B $0.07B -40.45%
2007-03-31 $-0.02B $0.04B -57.14%
2006-12-31 $-0.02B $0.03B -68.00%
2006-09-30 $-0.02B $0.04B -92.31%
2006-06-30 $-0.02B $0.01B -128.57%
2006-03-31 $-0.02B $0.02B -122.03%
2005-12-31 $-0.02B $0.01B -111.48%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.137B $0.000B
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $136.042B 9.43
Amgen (AMGN) United States $134.261B 14.00
CSL (CSLLY) Australia $96.737B 0.00
Gilead Sciences (GILD) United States $79.825B 8.98
Illumina (ILMN) United States $67.776B 103.23
Moderna (MRNA) United States $59.424B 0.00
Vertex Pharmaceuticals (VRTX) United States $56.266B 23.92
Regeneron Pharmaceuticals (REGN) United States $50.141B 16.39
Biogen (BIIB) United States $42.514B 8.50
Alexion Pharmaceuticals (ALXN) United States $33.621B 13.09
BeiGene (BGNE) Cayman Islands $30.413B 0.00
Seagen (SGEN) United States $28.448B 48.77
BioNTech SE (BNTX) Germany $26.961B 0.00
Genmab (GMAB) Denmark $24.055B 28.45
Exact Sciences (EXAS) United States $23.455B 0.00
Genmab (GNMSF) Denmark $21.894B 5.04
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.110B 0.00
Bio-Rad Laboratories (BIO.B) United States $19.836B 63.15
Horizon Therapeutics Public (HZNP) Ireland $18.601B 26.59
Alnylam Pharmaceuticals (ALNY) United States $17.926B 0.00
Incyte (INCY) United States $17.372B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.360B 0.00
Guardant Health (GH) United States $16.011B 0.00
Novavax (NVAX) United States $15.484B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.913B 98.98
Bio-Techne Corp (TECH) United States $14.622B 83.75
QIAGEN (QGEN) Netherlands $12.171B 24.86
Repligen (RGEN) United States $10.866B 154.11
CRISPR Therapeutics AG (CRSP) Switzerland $10.206B 0.00
Mirati Therapeutics (MRTX) United States $10.103B 0.00
Ultragenyx Pharmaceutical (RARE) United States $9.388B 0.00
Fate Therapeutics (FATE) United States $8.330B 0.00
Acceleron Pharma (XLRN) United States $8.280B 0.00
Ascendis Pharma (ASND) Denmark $8.167B 0.00
Vir Biotechnology (VIR) United States $8.134B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.908B 0.00
Adaptive Biotechnologies (ADPT) United States $7.763B 0.00
Denali Therapeutics (DNLI) United States $7.753B 0.00
Exelixis (EXEL) United States $6.931B 63.47
Sarepta Therapeutics (SRPT) United States $6.614B 0.00
Twist Bioscience (TWST) United States $6.581B 0.00
Halozyme Therapeutics (HALO) United States $6.382B 52.46
NeoGenomics (NEO) United States $5.883B 1766.33
Blueprint Medicines (BPMC) United States $5.648B 18.60
Beam Therapeutics (BEAM) United States $5.593B 0.00
Galapagos (GLPG) Belgium $5.585B 0.00
Certara (CERT) United States $5.547B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.025B 15.80
Emergent Biosolutions (EBS) United States $4.983B 11.91
China Biologic Products (CBPO) China $4.715B 30.56
Arena Pharmaceuticals (ARNA) United States $4.453B 0.00
I-Mab (IMAB) China $4.137B 0.00
Reata Pharmaceuticals (RETA) United States $4.131B 0.00
Insmed (INSM) United States $4.002B 0.00
Intellia Therapeutics (NTLA) United States $3.756B 0.00
Legend Biotech (LEGN) United States $3.666B 0.00
Arvinas (ARVN) United States $3.596B 0.00
NantKwest (NK) United States $3.529B 0.00
MorphoSys AG (MOR) Germany $3.405B 123.24
Alkermes (ALKS) Ireland $3.129B 0.00
Amicus Therapeutics (FOLD) United States $3.117B 0.00
Editas Medicine (EDIT) United States $3.081B 0.00
Global Blood Therapeutics (GBT) United States $2.968B 0.00
Intra-Cellular Therapies (ITCI) United States $2.957B 0.00
Viela Bio (VIE) United States $2.904B 0.00
Sorrento Therapeutics (SRNE) United States $2.894B 0.00
Amarin (AMRN) Ireland $2.811B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.526B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.413B 19.97
PHARMA MAR SA (PHMMF) Spain $2.401B 0.00
Ligand Pharmaceuticals (LGND) United States $2.270B 44.40
Genetron Holdings (GTH) China $2.262B 0.00
Myriad Genetics (MYGN) United States $2.183B 0.00
Inovio Pharmaceuticals (INO) United States $2.182B 0.00
Arcus Biosciences (RCUS) United States $2.161B 0.00
Vericel (VCEL) United States $2.152B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.040B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.018B 0.00
NGM Biopharmaceuticals (NGM) United States $1.947B 0.00
Seres Therapeutics (MCRB) United States $1.921B 0.00
Zymeworks (ZYME) Canada $1.881B 0.00
Heska (HSKA) United States $1.858B 0.00
Sangamo Therapeutics (SGMO) United States $1.744B 0.00
Revance Therapeutics (RVNC) United States $1.724B 0.00
Bluebird Bio (BLUE) United States $1.700B 0.00
Antibe Therapeutics (ATBPF) Canada $1.672B 0.00
Scholar Rock Holding (SRRK) United States $1.661B 0.00
Castle Biosciences (CSTL) United States $1.648B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.640B 0.00
Frequency Therapeutics (FREQ) United States $1.637B 0.00
UniQure (QURE) Netherlands $1.610B 0.00
Bionano Genomics (BNGO) United States $1.566B 0.00
Precigen (PGEN) United States $1.534B 0.00
Travere Therapeutics (TVTX) United States $1.514B 0.00
REGENXBIO (RGNX) United States $1.499B 0.00
Nurix Therapeutics (NRIX) United States $1.455B 0.00
Cytokinetics (CYTK) United States $1.434B 0.00
Alector (ALEC) United States $1.375B 0.00
Zealand Pharma (ZEAL) Denmark $1.367B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.330B 0.00
Codexis (CDXS) United States $1.314B 0.00
Mersana Therapeutics (MRSN) United States $1.305B 0.00
Adverum Biotechnologies (ADVM) United States $1.299B 0.00
MannKind (MNKD) United States $1.228B 0.00
Pliant Therapeutics (PLRX) United States $1.211B 0.00
Zealand Pharma (ZLDPF) Denmark $1.203B 0.00
Mesoblast (MESO) Australia $1.188B 0.00
Coherus BioSciences (CHRS) United States $1.170B 7.73
Northwest Biotherapeutics (NWBO) United States $1.123B 0.00
Athenex (ATNX) United States $1.111B 0.00
Celldex Therapeutics (CLDX) United States $1.096B 0.00
Morphic Holding (MORF) United States $1.061B 0.00
MiMedx (MDXG) United States $1.058B 0.00
Epizyme (EPZM) United States $1.057B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.057B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.026B 43.47
Avid Bioservices (CDMO) United States $1.015B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $1.013B 0.00
Dynavax Technologies (DVAX) United States $1.000B 0.00
Protagonist Therapeutics (PTGX) United States $0.984B 0.00
Cara Therapeutics (CARA) United States $0.981B 0.00
Cellectis S.A (CLLS) France $0.932B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.928B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.921B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.911B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.902B 0.00
Five Prime Therapeutics (FPRX) United States $0.891B 0.00
Prothena (PRTA) Ireland $0.843B 0.00
Sutro Biopharma (STRO) United States $0.841B 0.00
Pharming Group (PHGUF) Netherlands $0.832B 22.17
VBI Vaccines (VBIV) United States $0.816B 0.00
Agenus (AGEN) United States $0.796B 0.00
Kadmon Holdings (KDMN) United States $0.793B 0.00
Pandion Therapeutics (PAND) United States $0.741B 0.00
Cel-Sci (CVM) United States $0.732B 0.00
AnaptysBio (ANAB) United States $0.730B 0.00
Compugen (CGEN) Israel $0.719B 0.00
Starpharma Holdings (SPHRY) Australia $0.711B 0.00
ALBIREO PHARMA (ALBO) United States $0.702B 0.00
Merus (MRUS) Netherlands $0.690B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.666B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.623B 0.00
DBV Technologies S.A (DBVT) France $0.598B 0.00
MeiraGTx Holdings (MGTX) United States $0.596B 0.00
Geron (GERN) United States $0.596B 0.00
ChromaDex (CDXC) United States $0.589B 0.00
Curis (CRIS) United States $0.570B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.566B 0.00
Precision BioSciences (DTIL) United States $0.565B 0.00
Anika Therapeutics (ANIK) United States $0.542B 73.27
AC Immune SA (ACIU) Switzerland $0.539B 0.00
Clovis Oncology (CLVS) United States $0.531B 0.00
CorMedix Inc (CRMD) United States $0.530B 0.00
Amryt Pharma (AMYT) United Kingdom $0.519B 0.00
AquaBounty Technologies (AQB) United States $0.519B 0.00
Syros Pharmaceuticals (SYRS) United States $0.516B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.515B 0.00
Neoleukin Therapeutics (NLTX) United States $0.515B 0.00
AMMO (POWW) United States $0.514B 0.00
Spero Therapeutics (SPRO) United States $0.509B 0.00
Gritstone Oncology (GRTS) United States $0.508B 0.00
Kala Pharmaceuticals (KALA) United States $0.505B 0.00
WAVE Life Sciences (WVE) Singapore $0.474B 0.00
Affimed (AFMD) Germany $0.465B 0.00
Opthea (OPT) Australia $0.459B 0.00
Selecta Biosciences (SELB) United States $0.452B 0.00
UROGEN PHARMA (URGN) United States $0.449B 0.00
IBio (IBIO) United States $0.436B 0.00
Puma Biotechnology (PBYI) United States $0.433B 0.00
Athersys (ATHX) United States $0.431B 0.00
BioDelivery Sciences (BDSI) United States $0.427B 20.12
Cue Biopharma (CUE) United States $0.408B 0.00
Verastem (VSTM) United States $0.407B 0.00
XOMA (XOMA) United States $0.396B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.385B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.380B 0.00
CytomX Therapeutics (CTMX) United States $0.370B 0.00
Forte Biosciences (FBRX) United States $0.370B 0.00
Oncobiologics (OTLK) United States $0.368B 0.00
Cardiff Oncology (CRDF) United States $0.363B 0.00
ANI Pharmaceuticals (ANIP) United States $0.360B 9.16
Fortress Biotech (FBIO) United States $0.350B 0.00
Trevena (TRVN) United States $0.344B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.344B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.343B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.341B 0.00
Innate Pharma S.A (IPHA) France $0.336B 0.00
Arbutus Biopharma (ABUS) United States $0.325B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.320B 0.00
NextCure (NXTC) United States $0.312B 0.00
Bellus Health (BLU) Canada $0.302B 0.00
Kamada (KMDA) Israel $0.291B 16.74
PDL BioPharma (PDLI) United States $0.282B 0.00
Cerecor (CERC) United States $0.275B 0.00
Theratechnologies (THTX) Canada $0.274B 0.00
OSMOTICA PHARM (OSMT) United States $0.260B 0.00
HOOKIPA Pharma (HOOK) United States $0.251B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.249B 0.00
Voyager Therapeutics (VYGR) United States $0.242B 6.22
Aptinyx (APTX) United States $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.234B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.232B 0.00
Applied Genetic Technologies (AGTC) United States $0.231B 0.00
Checkpoint Therapeutics (CKPT) United States $0.228B 0.00
TELA Bio (TELA) United States $0.224B 0.00
Strongbridge Biopharma (SBBP) United States $0.223B 0.00
Eton Pharmaceuticals (ETON) United States $0.207B 0.00
Abeona Therapeutics (ABEO) United States $0.207B 0.00
VolitionRX (VNRX) United States $0.205B 0.00
Pluristem Therapeutics (PSTI) Israel $0.204B 0.00
GENFIT S.A (GNFT) France $0.203B 0.00
Exicure (XCUR) United States $0.201B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Kindred Biosciences (KIN) United States $0.188B 0.00
Protalix BioTherapeutics (PLX) Israel $0.184B 0.00
Nicox SA (NICXF) France $0.184B 0.00
Palatin Technologies (PTN) United States $0.182B 0.00
DiaMedica Therapeutics (DMAC) United States $0.177B 0.00
VTv Therapeutics (VTVT) United States $0.175B 0.00
Evogene (EVGN) Israel $0.170B 0.00
Clearside Biomedical (CLSD) United States $0.169B 0.00
Orgenesis (ORGS) United States $0.169B 350.00
Biofrontera AG (BFRA) Germany $0.168B 0.00
Cogent Biosciences (COGT) United States $0.163B 0.00
Seelos Therapeutics (SEEL) United States $0.162B 0.00
Liminal BioSciences (LMNL) Canada $0.161B 0.00
Dyadic (DYAI) United States $0.159B 0.00
Idera Pharmaceuticals (IDRA) United States $0.152B 0.00
Aptevo Therapeutics (APVO) United States $0.151B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Aytu Bioscience (AYTU) United States $0.141B 0.00
Synlogic (SYBX) United States $0.141B 0.00
Liquidia Technologies (LQDA) United States $0.136B 0.00
Cyclerion Therapeutics (CYCN) United States $0.134B 0.00
TRACON Pharmaceuticals (TCON) United States $0.130B 0.00
Catalyst Biosciences (CBIO) United States $0.130B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.130B 0.00
Beyond Air (XAIR) United States $0.128B 0.00
Lumos Pharma (LUMO) United States $0.124B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.120B 0.00
PHASEBIO PHARMA (PHAS) United States $0.118B 0.00
Cocrystal Pharma (COCP) United States $0.115B 0.00
Ecology Coatings (ABVC) United States $0.114B 0.00
ARAVIVE, INC (ARAV) United States $0.113B 0.00
Cidara Therapeutics (CDTX) United States $0.109B 0.00
Celyad SA (CYAD) Belgium $0.108B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.107B 0.00
Prima BioMed (IMMP) Australia $0.105B 0.00
Novogen (KZIA) Australia $0.103B 0.00
Stealth BioTherapeutics (MITO) United States $0.100B 45.25
Vascular Biogenics (VBLT) Israel $0.099B 0.00
Advaxis (ADXS) United States $0.098B 0.00
Adocia (ADOCY) France $0.092B 0.00
Windtree Therapeutics (WINT) United States $0.089B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Celsion (CLSN) United States $0.089B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.084B 0.00
Purple Biotech (PPBT) Israel $0.081B 0.00
Organovo Holdings (ONVO) United States $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.077B 0.00
AnPac Bio-Medical Science (ANPC) China $0.075B 0.00
AEterna Zentaris (AEZS) United States $0.073B 0.00
Cleveland BioLabs (CBLI) United States $0.073B 0.00
ARIDIS PHARMACT (ARDS) United States $0.068B 0.00
Genetic Technologies (GENE) Australia $0.067B 0.00
Edesa Biotech (EDSA) Canada $0.066B 0.00
Pulmatrix (PULM) United States $0.061B 0.00
Enveric Biosciences (ENVB) United States $0.055B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Appili Therapeutics (APLIF) Canada $0.054B 0.00
Happiness Biotech Group (HAPP) China $0.054B 0.00
BioCardia (BCDA) United States $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.049B 0.00
Yumanity Therapeutics (YMTX) United States $0.048B 0.00
ATyr Pharma (LIFE) United States $0.047B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.045B 0.00
AIkido Pharma (AIKI) United States $0.044B 0.00
Alimera Sciences (ALIM) United States $0.043B 0.00
IMMURON (IMRN) Australia $0.039B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.031B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.030B 0.00
Seneca Biopharma (SNCA) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
ThermoGenesis Holdings (THMO) United States $0.024B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Timber Pharmaceuticals (TMBR) United States $0.020B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Cyclo Therapeutics (CYTH) United States $0.013B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00